Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001329586 | SCV001521066 | uncertain significance | Developmental and epileptic encephalopathy, 60 | 2019-03-27 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV004035681 | SCV003874117 | uncertain significance | not specified | 2023-03-02 | criteria provided, single submitter | clinical testing | The c.199G>A (p.G67S) alteration is located in exon 2 (coding exon 2) of the CNPY3 gene. This alteration results from a G to A substitution at nucleotide position 199, causing the glycine (G) at amino acid position 67 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |